Tue.Apr 29, 2025

article thumbnail

Food Companies Race to Replace Artificial Colors With Natural Alternatives

Drugs.com

TUESDAY, April 29, 2025 The push to remove artificial colors from U.S. foods is gaining speed, but making the change won't be easy or quick.Last week, U.S. health officials directed food companies to voluntarily phase out petroleum-based syn.

252
252
article thumbnail

FDA misses approval deadline for a biotech’s rare disease drug

BioPharma Drive: Drug Pricing

The delay for Stealth Biotherapeutics comes amid a heightened focus on the impact FDA job cuts might have on drug reviews.

FDA 196
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Fathers' Depression Affects Kids' Future Behavior

Drugs.com

TUESDAY, April 29, 2025 Dads are supposed to be strong, steady and stoic, given how theyre portrayed in sitcoms and family entertainment.But in real life, fathers sometimes falter and brushing it off can have a devastating impact on their kids.

219
219
article thumbnail

New CAR-T Therapy achieves positive results in a high proportion of patients with a refractory type of lymphoma

Science Daily: Pharmacology News

A Phase I trial involving ten patients with relapsed or refractory classical Hodgkin lymphoma or T-cell lymphoma has achieved a 100% overall response rate and a 50% complete remission rate, in addition to a favorable safety profile and high in vivo persistence of CAR30+ cells.

Therapies 187
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Lifestyle Poses Greatest Risk For Cardiac Arrest

Drugs.com

TUESDAY, April 29, 2025 -- Nearly two-thirds of cardiac arrest cases could be prevented by managing lifestyle, environmental and personal health risks, a new study says.Researchers found that addressing 56 everyday risk factors for sudden cardiac.

218
218

More Trending

article thumbnail

No Greater Risk Of Brain Aging Among People With Autism

Drugs.com

TUESDAY, April 29, 2025 -- People with autism do not appear to be at greater risk of age-related brain decline, a new study says.Older people with autistic traits have no differences when it comes to spatial working memory, which helps folks.

195
195
article thumbnail

Greasing the wheels of the energy transition to address climate change and fossil fuels phase out

Science Daily: Pharmacology News

The global energy system may be faced with an inescapable trade-off between urgently addressing climate change versus avoiding an energy shortfall, according to a new energy scenario tool.

169
169
article thumbnail

Abeona cell therapy approved by FDA for rare skin condition

BioPharma Drive: Drug Pricing

Zevaskyn, which Abeona priced at $3.1 million, treats epidermolysis bullosa. It will compete with a gene therapy from Krystal Biotech that is off to a strong sales start.

Therapies 164
article thumbnail

FDA Approves Zevaskyn for Rare, Genetic Skin Disorder

Drugs.com

TUESDAY, April 29, 2025 -- The U.S. Food and Drug Administration has approved Zevaskyn (prademagene zamikeracel) for patients with the rare, genetic skin disorder recessive dystrophic epidermolysis bullosa.Zevaskyn is the first and only autologous.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Palatable versus poisonous: Eavesdropping bats must learn to identify which prey is safe to eat

Science Daily: Pharmacology News

Scientists found that the fringe-lipped bat, known to eavesdrop on frog and toad mating calls to find its prey, learns to distinguish between palatable and unpalatable frogs and toads through experience. The findings provide the first evidence that eavesdropping predators fine-tune their hunting cues over the course of their development.

161
161
article thumbnail

Acelyrin should liquidate instead of merging with Alumis, investor says

BioPharma Drive: Drug Pricing

Trium Capital is the latest firm to push a biotech “zombie” to shut down, claiming in a regulatory filing there is more upside to a liquidation than Acelyrin’s planned merger.

154
154
article thumbnail

Telemedicine Cuts Down On Greenhouse Gases

Drugs.com

TUESDAY, April 29, 2025 -- Telemedicine isnt only more convenient for patients, but could be helping save the planet, a new study says.Telemedicine use in 2023 reduced monthly carbon dioxide emissions by the equivalent of more than 130,000 e.

147
147
article thumbnail

Novo partners with telehealth companies in move to expand Wegovy market

BioPharma Drive: Drug Pricing

Deals with Hims & Hers, LifeMD and Ro following a court's dismissal of a lawsuit challenging the FDA's determination that Wegovy is no longer in shortage.

Marketing 154
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

HHS Clarifies: No New Autism Registry Will Be Created

Drugs.com

TUESDAY, April 29, 2025 The U.S. Department of Health and Human Services (HHS) said it will not create a new autism registry, reversing an earlier announcement from the National Institutes of Health (NIH)."We are not creating an autism registry. T.

147
147
article thumbnail

The Role of Clinical Trial Data Visualisation in Modern Drug Development

Quanticate

Clinical research is evolving as technology advancements enable more sophisticated drug development methods, dramatically increasing the speed, volume, and complexity of clinical trial data generation. Continuous data monitoring is now essential as sponsors must track ever-larger datasets to safeguard patient safety, data quality, and regulatory compliance.

article thumbnail

Sitting Too Long Each Day May Lead to Neck Pain, Study Finds

Drugs.com

TUESDAY, April 29, 2025 If you spend hours a day glued to your phone or seated at a desk, you're setting yourself up for serious neck pain, a recent study warns.Researchers in China looked at data from 25 studies involving more than 43,000 people.

130
130
article thumbnail

ELRIG Announces USA Forum on Neuroimmunology in Drug Discovery

Elrig

ELRIG Announces USA Forum on Neuroimmunology in Drug Discovery ELRIGs USA Forum will take place in Boston, MA, USA, on 24 June 2025 Event will focus on Neuroimmunology in Drug Discovery Cambridge, UK, 29th April 2025: The European Laboratory Research & Innovation Group (ELRIG), a not-for-profit, volunteer-led organisation for the drug discovery community, today announced its first USA Forum.

Drugs 52
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Pushing for innovation amid a ‘silent surge’ of rising MASH rates

Fierce BioTech

By Naim Alkhouri, MD,FAASLD, DABOM. | How a commonly silent disease is driving urgency and novelty in the liver disease treatment paradigm and what can we hope for.

Disease 52
article thumbnail

Protected: FUEL Leverages Halo to Support Energy Innovation Across Louisiana

Translation

This content is password protected. To view it please enter your password below: Password: The post Protected: FUEL Leverages Halo to Support Energy Innovation Across Louisiana appeared first on Translation | Halo Blog.

52
article thumbnail

Crucial Data Solutions Sets Another Industry Benchmark: TrialKit Now Available as a Native macOS App

Crucial Data Solutions

The only eClinical platform to offer native web, mobile (iOS/Android), and Mac applications, redefining the standard for modern research software. The post Crucial Data Solutions Sets Another Industry Benchmark: TrialKit Now Available as a Native macOS App appeared first on Crucial Data Solutions.

article thumbnail

Fate Worse Than Death: Many Long-Term Care Residents Lose All Independence, Study Says

Drugs.com

TUESDAY, April 29, 2025 -- A significant number of long-term care patients consider their state a fate worse than death, as they become completely powerless and vulnerable due to their severe disabilities, a new study says.About 20% of people newly.

200
200
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Giant croclike carnivore fossils found in the Caribbean

Science Daily: Pharmacology News

Imagine a crocodile built like a greyhound -- that's a sebecid. Standing tall, with some species reaching 20 feet in length, they dominated South American landscapes after the extinction of dinosaurs until about 11 million years ago. Or at least, that's what paleontologists thought. A new study shows the Caribbean Islands were a refuge for the last sebecid populations at least 5 million years after they went extinct everywhere else.

246
246
article thumbnail

Phthalates Linked To Heart Disease Deaths Globally

Drugs.com

TUESDAY, April 29, 2025 -- Chemicals commonly used in plastics appear to increase peoples risk of heart disease, a new study says.Daily exposure to just one type of phthalate could be linked to more than 365,000 deaths worldwide from heart disease.

Disease 200
article thumbnail

Rainfall triggers extreme humid heat in tropics and subtropics

Science Daily: Pharmacology News

Scientists believe they have found a way to improve warning systems for vulnerable communities threatened by humid heatwaves, which are on the rise due to climate change and can be damaging and even fatal to human health. The study analysed how patterns of recent rainfall can interact with dry or moist land conditions to influence the risk of extreme humid heat in the global tropics and subtropics.

213
213
article thumbnail

New Viral Vectors - Spring 2025

addgene Blog

Addgenes viral vector services allow scientists to conduct experiments faster, skipping the preparation steps of production, purification, and titering. Our newest viral vector service, AAV Packaged on Request has seen a fantastic response from the research community. Customers have taken advantage of the customizability, choosing the cargo, serotype, and prep size they need for their experiments and weve been able to ship them out in record time.

article thumbnail

Rare Disease Day 2025: Rally for Rare Event Recap

Conversations in Drug Development Trends

On the last day of February every year is Rare Disease Day , a dedicated day to celebrate the rare disease community, including patients, families, caregivers, clinicians, researchers, regulators, and more. The day inspires multiple events, such as fundraisers and scientific symposia, to bring together all the critical stakeholders who tirelessly work to make life better for those affected by rare diseases.

Disease 69
article thumbnail

Identifying and Invalidating Weak Drug Patents in the United States

Drug Patent Watch

"Patent Infringement Alert: Are You Sitting on a Goldmine? Did you know that over 40% of pharmaceutical patents in the US are considered "weak" due to flawed patent applications or inadequate patent prosecution? At DrugPatentWatch, we've identified a staggering number of opportunities for generic manufacturers to invalidate these weak patents and bring affordable medications to market.

Drugs 57
article thumbnail

Strapi:Unleash the Power to Build Modern,Highly Customizable Websites with the Ultimate Headless CMS

Perficient: Drug Development

Strapi is the leading open-source headless CMS. It’s 100% JavaScript/ TypeScript , fully customizable, and developer-first. Its flexibility and scalability make it an ideal choice for businesses and organizations seeking to create unique digital experiences. Self-hosted or Cloud : We can host and scale Strapi (open-source headless CMS) projects the way you want.

article thumbnail

The Role of Market Access in Generic Drug Commercialization

Drug Patent Watch

"Market Access: The Hidden Hurdle in Generic Drug Commercialization As a seasoned pharmaceutical professional, I've seen it time and time again: a generic drug finally receives FDA approval, only to stall in the market due to a seemingly insurmountable obstacle - market access. But what exactly is market access, and why does it hold such sway over the commercialization of generic drugs?